A Study Understanding How Much CDR132L Enters the Bloodstream After Injection Under the Skin Compared to Injection Into a Vein in Healthy Participants

NCT07656454 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Heart Failure

Interventions

DRUG: CDR132L (i.v.)
DRUG: CDR132L (s.c.)

Sponsor

Novo Nordisk A/S